Skip to main content

Table 6 Univariate and multivariate analyses of OS in MBC patients receiving chemotherapy

From: Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis

 

OS

Univariate analysis

Multivariate analysis

HR

P value

HR

P value

Preoperative chemotherapy

4.70(1.75–12.63)

 < 0.01

3.33(0.97–11.39)

0.06

Anthracycline therapy

1.48(0.20–11.23)

0.70

  

Taxane therapy

0.72(0.16–3.16)

0.66

  

Platinum therapy

4.84(1.66–14.14)

 < 0.01

1.95(0.51–7.35)

0.33

  1. DFS disease-free survival, HR hazard ratio, OS overall survival, HR hazard ratio
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us